Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$2.56
-0.06-2.29%
Last update: Oct 2, 4:00 AM
$2.59
-0.03-1.15%
Nkarta Inc (NKTX) Stock Price, Quote, News & History
NKTXNASDAQ
| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
Nkarta Inc is a clinical-stage biopharmaceutical company pioneering the development of allogeneic, off-the-shelf engineered natural killer (NK) cell therapies. The company is engaged in leveraging the natural potent power of NK cells to identify and...
Benzinga Rankings give you vital metrics on any stock – anytime.
You can purchase shares of Nkarta (NASDAQ:NKTX) through any online brokerage.
Other companies in Nkarta’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Regeneron Pharmaceuticals Inc (NASDAQ:REGN).
Nkarta has a consensus price target of $13.00.
The stock price for Nkarta (NASDAQ: NKTX) is $2.59 last updated October 2, 2026 at 4:00 AM EDT.
There are no upcoming dividends for Nkarta.
Nkarta does not have any upcoming earnings scheduled.
There is no upcoming split for Nkarta.
Nkarta is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
